Inhalation Sciences AB - Breathing New Life into Inhalation R&D
Omicron are pleased to announce a new partnership as the sole agents for Inhalation Sciences in the UK
About Inhalation Sciences
Inhalation Sciences develops and sells patented, highly innovative labtech equipment for inhalation research. Scientists using it can now know, with unprecedented accuracy, how particles behave in our lungs when we inhale them: whether new pollutants or life-saving drugs that power human development.
The company was founded in 2004 based on key innovations made by Dr. Per Gerde. The technology was validated by collaborations and contract research services until 2014 when the first instrument was delivered and installed. Inhalation Sciences was introduced on the Swedish stock exchange in 2017. Today, the company delivers its technology and services on a global market, having systems installed in Europe, USA and Asia.